This is likely not the case, and the expression of a-SMA in pancreatic cancer tissues is unstable and provides no predictive value in the prognosis of patients (Erkan et al., 2008; Moffitt et al., 2015; Haeberle et al., 2018). The gene discussed is SMN1; the disease is familial pancreatic carcinoma.